schliessen

Filtern

 

Bibliotheken

Analyzing the protection scope limit for biosequence patent claims in China

Though a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.

Journal Title: Nature biotechnology 2018-09-06, Vol.36 (9), p.811-813
Main Author: Li, Wei
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: United States: Nature Publishing Group
ID: ISSN: 1087-0156
Link: https://www.ncbi.nlm.nih.gov/pubmed/30188533
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_2100327738
title: Analyzing the protection scope limit for biosequence patent claims in China
format: Article
creator:
  • Li, Wei
subjects:
  • Amino acids
  • DNA sequencing
  • Enzymes
  • Fungi
  • Intellectual property
  • Methods
  • Nucleotide sequencing
  • Patent law
  • Patents
  • Polypeptides
  • Proteins
ispartof: Nature biotechnology, 2018-09-06, Vol.36 (9), p.811-813
description: Though a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.
language: eng
source:
identifier: ISSN: 1087-0156
fulltext: no_fulltext
issn:
  • 1087-0156
  • 1546-1696
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.5282505
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_2100327738
sourceformatXML
sourcesystemPC
galeidA572644895
sourcerecordidA572644895
originalsourceidFETCH-LOGICAL-c500t-36288204c603153472acdb7ce92797f64e971d2da64722b6f0ad9cc12d420dd00
addsrcrecordideNqNkl1rFDEUhoMotlbBXyABbxSc9eRjMsnlslQtLRT8ug2ZTGY3ZSZZJxmw_fVm6Wq7IlICySF53pOTkxehlwQWBJh8H9q84JTxR-iY1FxURCjxuMQgmwpILY7Qs5SuAEBwIZ6iIwZEypqxY3S-DGa4vvFhjfPG4e0Us7PZx4CTjVuHBz_6jPs44dbH5H7MLtiCmexCxnYwfkzYB7za-GCeoye9GZJ7sV9P0LcPp19Xn6qLy49nq-VFZWuAXDFBpaTArQBGasYbamzXNtYp2qimF9yphnS0M6Ic0Vb0YDplLaEdp9B1ACfozW3eUm0pKGU9-mTdMJjg4pw0JQCMNg2TBX39F3oV56k8uVCMKKKg9OG_FKGcKMkEv6PWZnDahz7mydjd1XpZN1RwLtUu1-IfVBmdG72NwfW-7B8I3h4ICpPdz7w2c0r67Mvnh7OX3w_Zd_fYdk4-uFSm5NebnG4lSwHFKSBLHx6E38--_wM7xZQm1-vt5EczXWsCeudJXTypd54s6Kt9d-d2dN0f8LcJ4ReOO9Ws
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid2124198364
display
typearticle
titleAnalyzing the protection scope limit for biosequence patent claims in China
creatorLi, Wei
creatorcontribLi, Wei
descriptionThough a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.
identifier
0ISSN: 1087-0156
1EISSN: 1546-1696
2DOI: 10.1038/nbt.4234
3PMID: 30188533
languageeng
publisherUnited States: Nature Publishing Group
subjectAmino acids ; DNA sequencing ; Enzymes ; Fungi ; Intellectual property ; Methods ; Nucleotide sequencing ; Patent law ; Patents ; Polypeptides ; Proteins
ispartofNature biotechnology, 2018-09-06, Vol.36 (9), p.811-813
rights
0COPYRIGHT 2018 Nature Publishing Group
1Copyright Nature Publishing Group Sep 2018
2Copyright Nature Publishing Group Oct 2018
lds50peer_reviewed
citesFETCH-LOGICAL-c500t-36288204c603153472acdb7ce92797f64e971d2da64722b6f0ad9cc12d420dd00
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30188533$$D View this record in MEDLINE/PubMed
search
creatorcontribLi, Wei
title
0Analyzing the protection scope limit for biosequence patent claims in China
1Nature biotechnology
addtitleNat Biotechnol
descriptionThough a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.
subject
0Amino acids
1DNA sequencing
2Enzymes
3Fungi
4Intellectual property
5Methods
6Nucleotide sequencing
7Patent law
8Patents
9Polypeptides
10Proteins
issn
01087-0156
11546-1696
fulltextfalse
rsrctypearticle
creationdate2018
recordtypearticle
recordideNqNkl1rFDEUhoMotlbBXyABbxSc9eRjMsnlslQtLRT8ug2ZTGY3ZSZZJxmw_fVm6Wq7IlICySF53pOTkxehlwQWBJh8H9q84JTxR-iY1FxURCjxuMQgmwpILY7Qs5SuAEBwIZ6iIwZEypqxY3S-DGa4vvFhjfPG4e0Us7PZx4CTjVuHBz_6jPs44dbH5H7MLtiCmexCxnYwfkzYB7za-GCeoye9GZJ7sV9P0LcPp19Xn6qLy49nq-VFZWuAXDFBpaTArQBGasYbamzXNtYp2qimF9yphnS0M6Ic0Vb0YDplLaEdp9B1ACfozW3eUm0pKGU9-mTdMJjg4pw0JQCMNg2TBX39F3oV56k8uVCMKKKg9OG_FKGcKMkEv6PWZnDahz7mydjd1XpZN1RwLtUu1-IfVBmdG72NwfW-7B8I3h4ICpPdz7w2c0r67Mvnh7OX3w_Zd_fYdk4-uFSm5NebnG4lSwHFKSBLHx6E38--_wM7xZQm1-vt5EczXWsCeudJXTypd54s6Kt9d-d2dN0f8LcJ4ReOO9Ws
startdate20180906
enddate20180906
creatorLi, Wei
generalNature Publishing Group
scope
0NPM
1AAYXX
2CITATION
33V.
47QO
57QP
67QR
77T7
87TK
97TM
107X7
117XB
1288A
1388E
1488I
158AO
168FD
178FE
188FG
198FH
208FI
218FJ
228FK
238G5
24ABJCF
25ABUWG
26AZQEC
27BBNVY
28BENPR
29BGLVJ
30BHPHI
31C1K
32DWQXO
33FR3
34FYUFA
35GHDGH
36GNUQQ
37GUQSH
38HCIFZ
39K9.
40L6V
41LK8
42M0S
43M1P
44M2O
45M2P
46M7P
47M7S
48MBDVC
49P64
50PADUT
51PQEST
52PQQKQ
53PQUKI
54PRINS
55PTHSS
56Q9U
57RC3
587X8
sort
creationdate20180906
titleAnalyzing the protection scope limit for biosequence patent claims in China
authorLi, Wei
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c500t-36288204c603153472acdb7ce92797f64e971d2da64722b6f0ad9cc12d420dd00
rsrctypearticles
prefilterarticles
languageeng
creationdate2018
topic
0Amino acids
1DNA sequencing
2Enzymes
3Fungi
4Intellectual property
5Methods
6Nucleotide sequencing
7Patent law
8Patents
9Polypeptides
10Proteins
toplevelpeer_reviewed
creatorcontribLi, Wei
collection
0PubMed
1CrossRef
2ProQuest Central (Corporate)
3Biotechnology Research Abstracts
4Calcium & Calcified Tissue Abstracts
5Chemoreception Abstracts
6Industrial and Applied Microbiology Abstracts (Microbiology A)
7Neurosciences Abstracts
8Nucleic Acids Abstracts
9Health & Medical Collection
10ProQuest Central (purchase pre-March 2016)
11Biology Database (Alumni Edition)
12Medical Database (Alumni Edition)
13Science Database (Alumni Edition)
14ProQuest Pharma Collection
15Technology Research Database
16ProQuest SciTech Collection
17ProQuest Technology Collection
18ProQuest Natural Science Collection
19Hospital Premium Collection
20Hospital Premium Collection (Alumni Edition)
21ProQuest Central (Alumni) (purchase pre-March 2016)
22Research Library (Alumni Edition)
23Materials Science & Engineering Collection
24ProQuest Central (Alumni Edition)
25ProQuest Central Essentials
26Biological Science Collection
27ProQuest Central
28Technology Collection
29Natural Science Collection
30Environmental Sciences and Pollution Management
31ProQuest Central Korea
32Engineering Research Database
33Health Research Premium Collection
34Health Research Premium Collection (Alumni)
35ProQuest Central Student
36Research Library Prep
37SciTech Premium Collection
38ProQuest Health & Medical Complete (Alumni)
39ProQuest Engineering Collection
40ProQuest Biological Science Collection
41Health & Medical Collection (Alumni Edition)
42Medical Database
43Research Library
44Science Database
45Biological Science Database
46Engineering Database
47Research Library (Corporate)
48Biotechnology and BioEngineering Abstracts
49Research Library China
50ProQuest One Academic Eastern Edition
51ProQuest One Academic
52ProQuest One Academic UKI Edition
53ProQuest Central China
54Engineering Collection
55ProQuest Central Basic
56Genetics Abstracts
57MEDLINE - Academic
jtitleNature biotechnology
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
auLi, Wei
formatjournal
genrearticle
ristypeJOUR
atitleAnalyzing the protection scope limit for biosequence patent claims in China
jtitleNature biotechnology
addtitleNat Biotechnol
date2018-09-06
risdate2018
volume36
issue9
spage811
epage813
pages811-813
issn1087-0156
eissn1546-1696
abstractThough a patent's protection scope should be based on the content of the claims and written description, determining the protection scope of a biosequence patent has always been a controversial issue in practice.
copUnited States
pubNature Publishing Group
pmid30188533
doi10.1038/nbt.4234
tpages3